-
1
-
-
79953705357
-
Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma
-
Löscher W, Schmidt D Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 2011, 52:657-678.
-
(2011)
Epilepsia
, vol.52
, pp. 657-678
-
-
Löscher, W.1
Schmidt, D.2
-
2
-
-
84857648355
-
Identification of new epilepsy treatments: issues in preclinical methodology
-
the American Epilepsy Society Basic Science Committee, The International League Against Epilepsy Working Group On Recommendations For Preclinical Epilepsy Drug DiscoveryThe International League Against Epilepsy Working Group On Recommendations For Preclinical Epilepsy Drug Discovery
-
Galanopoulou AS, Buckmaster PS, Staley KJ, et al. Identification of new epilepsy treatments: issues in preclinical methodology. Epilepsia 2012, 53:571-582. the American Epilepsy Society Basic Science Committee, The International League Against Epilepsy Working Group On Recommendations For Preclinical Epilepsy Drug DiscoveryThe International League Against Epilepsy Working Group On Recommendations For Preclinical Epilepsy Drug Discovery.
-
(2012)
Epilepsia
, vol.53
, pp. 571-582
-
-
Galanopoulou, A.S.1
Buckmaster, P.S.2
Staley, K.J.3
-
3
-
-
66849097996
-
Update of the stroke therapy academic industry roundtable preclinical recommendations
-
the STAIR Group
-
Fisher M, Feuerstein G, Howells DW, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009, 40:2244-2250. the STAIR Group.
-
(2009)
Stroke
, vol.40
, pp. 2244-2250
-
-
Fisher, M.1
Feuerstein, G.2
Howells, D.W.3
-
4
-
-
84862297965
-
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies
-
Shineman DW, Basi GS, Bizon JL, et al. Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies. Alzheimers Res Ther 2011, 3:28.
-
(2011)
Alzheimers Res Ther
, vol.3
, pp. 28
-
-
Shineman, D.W.1
Basi, G.S.2
Bizon, J.L.3
-
5
-
-
84856531446
-
Replication and reproducibility in spinal cord injury research
-
Steward O, Popovich PG, Dietrich WD, Kleitman N Replication and reproducibility in spinal cord injury research. Exp Neurol 2012, 233:597-605.
-
(2012)
Exp Neurol
, vol.233
, pp. 597-605
-
-
Steward, O.1
Popovich, P.G.2
Dietrich, W.D.3
Kleitman, N.4
-
6
-
-
77649285022
-
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
-
Ludolph AC, Bendotti C, Blaugrund E, et al. Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotroph Lateral Scler 2010, 11:38-45.
-
(2010)
Amyotroph Lateral Scler
, vol.11
, pp. 38-45
-
-
Ludolph, A.C.1
Bendotti, C.2
Blaugrund, E.3
-
7
-
-
84888201969
-
Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy
-
Brooks-Kayal AR, Bath KG, Berg AT, et al. Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy. Epilepsia 2013, 54(suppl 4):44-60.
-
(2013)
Epilepsia
, vol.54
, Issue.SUPPL. 4
, pp. 44-60
-
-
Brooks-Kayal, A.R.1
Bath, K.G.2
Berg, A.T.3
-
8
-
-
84891679696
-
Epilepsy therapy development: technical and methodologic issues in studies with animal models
-
Galanopoulou AS, Kokaia M, Loeb JA, et al. Epilepsy therapy development: technical and methodologic issues in studies with animal models. Epilepsia 2013, 54(suppl 4):13-23.
-
(2013)
Epilepsia
, vol.54
, Issue.SUPPL. 4
, pp. 13-23
-
-
Galanopoulou, A.S.1
Kokaia, M.2
Loeb, J.A.3
-
9
-
-
77953781386
-
A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible
-
Hooijmans CR, Leenaars M, Ritskes-Hoitinga M A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible. Altern Lab Anim 2010, 38:167-182.
-
(2010)
Altern Lab Anim
, vol.38
, pp. 167-182
-
-
Hooijmans, C.R.1
Leenaars, M.2
Ritskes-Hoitinga, M.3
-
10
-
-
84872759925
-
Successfully Climbing the "STAIRs": Surmounting Failed Translation of Experimental Ischemic Stroke Treatments
-
Kahle MP, Bix GJ Successfully Climbing the "STAIRs": Surmounting Failed Translation of Experimental Ischemic Stroke Treatments. Stroke Res Treat 2012, 2012:374098.
-
(2012)
Stroke Res Treat
, vol.2012
, pp. 374098
-
-
Kahle, M.P.1
Bix, G.J.2
-
11
-
-
85041813459
-
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research
-
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010, 8:e1000412.
-
(2010)
PLoS Biol
, vol.8
-
-
Kilkenny, C.1
Browne, W.J.2
Cuthill, I.C.3
Emerson, M.4
Altman, D.G.5
-
12
-
-
84867302438
-
A call for transparent reporting to optimize the predictive value of preclinical research
-
Landis SC, Amara SG, Asadullah K, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 2012, 490:187-191.
-
(2012)
Nature
, vol.490
, pp. 187-191
-
-
Landis, S.C.1
Amara, S.G.2
Asadullah, K.3
-
13
-
-
84871840994
-
Making methods clearer
-
Editorial
-
Making methods clearer. Nat Neurosci 2013, 16:1. Editorial.
-
(2013)
Nat Neurosci
, vol.16
, pp. 1
-
-
-
15
-
-
84869088933
-
Finding a better drug for epilepsy: preclinical screening strategies and experimental trial design
-
Simonato M, Löscher W, Cole AJ, et al. Finding a better drug for epilepsy: preclinical screening strategies and experimental trial design. Epilepsia 2012, 53:1860-1867.
-
(2012)
Epilepsia
, vol.53
, pp. 1860-1867
-
-
Simonato, M.1
Löscher, W.2
Cole, A.J.3
-
16
-
-
84874941208
-
Issues for new antiepilepsy drug development
-
Simonato M, French JA, Galanopoulou AS, O'Brien TJ Issues for new antiepilepsy drug development. Curr Opin Neurol 2013, 26:195-200.
-
(2013)
Curr Opin Neurol
, vol.26
, pp. 195-200
-
-
Simonato, M.1
French, J.A.2
Galanopoulou, A.S.3
O'Brien, T.J.4
-
17
-
-
84885022384
-
New avenues for anti-epileptic drug discovery and development
-
Löscher W, Klitgaard H, Twyman RE, Schmidt D New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 2013, 12:757-776.
-
(2013)
Nat Rev Drug Discov
, vol.12
, pp. 757-776
-
-
Löscher, W.1
Klitgaard, H.2
Twyman, R.E.3
Schmidt, D.4
-
18
-
-
16344387731
-
Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)
-
Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46:470-472.
-
(2005)
Epilepsia
, vol.46
, pp. 470-472
-
-
Fisher, R.S.1
van Emde Boas, W.2
Blume, W.3
-
19
-
-
84899493269
-
A practical clinical definition of epilepsy
-
Fisher RS, Acevedo C, Arzimanoglou A, et al. A practical clinical definition of epilepsy. Epilepsia 2014, 55:475-482.
-
(2014)
Epilepsia
, vol.55
, pp. 475-482
-
-
Fisher, R.S.1
Acevedo, C.2
Arzimanoglou, A.3
-
20
-
-
84891698175
-
Issues related to development of antiepileptogenic therapies
-
Pitkänen A, Nehlig A, Brooks-Kayal AR, et al. Issues related to development of antiepileptogenic therapies. Epilepsia 2013, 54(suppl 4):35-43.
-
(2013)
Epilepsia
, vol.54
, Issue.SUPPL. 4
, pp. 35-43
-
-
Pitkänen, A.1
Nehlig, A.2
Brooks-Kayal, A.R.3
-
21
-
-
77954625557
-
Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
-
Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010, 51:1069-1077.
-
(2010)
Epilepsia
, vol.51
, pp. 1069-1077
-
-
Kwan, P.1
Arzimanoglou, A.2
Berg, A.T.3
-
22
-
-
84891676185
-
Issues related to development of new antiseizure treatments
-
Wilcox KS, Dixon-Salazar T, Sills GJ, et al. Issues related to development of new antiseizure treatments. Epilepsia 2013, 54(suppl 4):24-34.
-
(2013)
Epilepsia
, vol.54
, Issue.SUPPL. 4
, pp. 24-34
-
-
Wilcox, K.S.1
Dixon-Salazar, T.2
Sills, G.J.3
-
23
-
-
84888381473
-
Epilepsy biomarkers
-
Engel J, Pitkänen A, Loeb JA, et al. Epilepsy biomarkers. Epilepsia 2013, 54(suppl 4):61-69.
-
(2013)
Epilepsia
, vol.54
, Issue.SUPPL. 4
, pp. 61-69
-
-
Engel, J.1
Pitkänen, A.2
Loeb, J.A.3
-
24
-
-
23244451582
-
Biomarkers and surrogate markers: an FDA perspective
-
Katz R Biomarkers and surrogate markers: an FDA perspective. NeuroRx 2004, 1:189-195.
-
(2004)
NeuroRx
, vol.1
, pp. 189-195
-
-
Katz, R.1
-
26
-
-
84891673132
-
Development of new treatment approaches for epilepsy: unmet needs and opportunities
-
French JA, White HS, Klitgaard H, et al. Development of new treatment approaches for epilepsy: unmet needs and opportunities. Epilepsia 2013, 54(suppl 4):3-12.
-
(2013)
Epilepsia
, vol.54
, Issue.SUPPL. 4
, pp. 3-12
-
-
French, J.A.1
White, H.S.2
Klitgaard, H.3
-
27
-
-
42949140259
-
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
-
Zeng LH, Xu L, Gutmann DH, Wong M Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 2008, 63:444-453.
-
(2008)
Ann Neurol
, vol.63
, pp. 444-453
-
-
Zeng, L.H.1
Xu, L.2
Gutmann, D.H.3
Wong, M.4
-
28
-
-
84890806945
-
Everolimus treatment of refractory epilepsy in tuberous sclerosis complex
-
Krueger DA, Wilfong AA, Holland-Bouley K, et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 2013, 74:679-687.
-
(2013)
Ann Neurol
, vol.74
, pp. 679-687
-
-
Krueger, D.A.1
Wilfong, A.A.2
Holland-Bouley, K.3
-
29
-
-
70350787254
-
Epileptogenesis in the immature brain: emerging mechanisms
-
Rakhade SN, Jensen FE Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol 2009, 5:380-391.
-
(2009)
Nat Rev Neurol
, vol.5
, pp. 380-391
-
-
Rakhade, S.N.1
Jensen, F.E.2
-
30
-
-
82255160632
-
Disparities in NIH funding for epilepsy research
-
Meador KJ, French J, Loring DW, Pennell PB Disparities in NIH funding for epilepsy research. Neurology 2011, 77:1305-1307.
-
(2011)
Neurology
, vol.77
, pp. 1305-1307
-
-
Meador, K.J.1
French, J.2
Loring, D.W.3
Pennell, P.B.4
-
31
-
-
78751488401
-
Mechanisms of epileptogenesis and potential treatment targets
-
Pitkänen A, Lukasiuk K Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 2011, 10:173-186.
-
(2011)
Lancet Neurol
, vol.10
, pp. 173-186
-
-
Pitkänen, A.1
Lukasiuk, K.2
-
32
-
-
39749159858
-
Early treatment suppresses the development of spike-wave epilepsy in a rat model
-
Blumenfeld H, Klein JP, Schridde U, et al. Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia 2008, 49:400-409.
-
(2008)
Epilepsia
, vol.49
, pp. 400-409
-
-
Blumenfeld, H.1
Klein, J.P.2
Schridde, U.3
-
33
-
-
84875859244
-
Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy
-
Dezsi G, Ozturk E, Stanic D, et al. Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy. Epilepsia 2013, 54:635-643.
-
(2013)
Epilepsia
, vol.54
, pp. 635-643
-
-
Dezsi, G.1
Ozturk, E.2
Stanic, D.3
-
34
-
-
84877927616
-
Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man study
-
Cook MJ, O'Brien TJ, Berkovic SF, et al. Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man study. Lancet Neurol 2013, 12:563-571.
-
(2013)
Lancet Neurol
, vol.12
, pp. 563-571
-
-
Cook, M.J.1
O'Brien, T.J.2
Berkovic, S.F.3
-
35
-
-
85027950708
-
Seizure diaries for clinical research and practice: limitations and future prospects
-
Fisher RS, Blum DE, DiVentura B, et al. Seizure diaries for clinical research and practice: limitations and future prospects. Epilepsy Behav 2012, 24:304-310.
-
(2012)
Epilepsy Behav
, vol.24
, pp. 304-310
-
-
Fisher, R.S.1
Blum, D.E.2
DiVentura, B.3
-
36
-
-
80054825753
-
Biomarkers in epilepsy: introduction
-
Engel J Biomarkers in epilepsy: introduction. Biomarkers Med 2011, 5:537-544.
-
(2011)
Biomarkers Med
, vol.5
, pp. 537-544
-
-
Engel, J.1
-
37
-
-
84865355051
-
High-frequency oscillations - where we are and where we need to go
-
Engel J, da Silva FL High-frequency oscillations - where we are and where we need to go. Prog Neurobiol 2012, 98:316-318.
-
(2012)
Prog Neurobiol
, vol.98
, pp. 316-318
-
-
Engel, J.1
da Silva, F.L.2
-
38
-
-
80054828173
-
High-frequency oscillations and other electrophysiological biomarkers of epilepsy: clinical studies
-
Worrell G, Gotman J High-frequency oscillations and other electrophysiological biomarkers of epilepsy: clinical studies. Biomarkers Med 2011, 5:557-566.
-
(2011)
Biomarkers Med
, vol.5
, pp. 557-566
-
-
Worrell, G.1
Gotman, J.2
-
39
-
-
80054807184
-
Prospects for imaging-related biomarkers of human epileptogenesis: a critical review
-
Gomes WA, Shinnar S Prospects for imaging-related biomarkers of human epileptogenesis: a critical review. Biomarkers Med 2011, 5:599-606.
-
(2011)
Biomarkers Med
, vol.5
, pp. 599-606
-
-
Gomes, W.A.1
Shinnar, S.2
-
40
-
-
80054811727
-
11C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies
-
11C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies. Biomarkers Med 2011, 5:577-584.
-
(2011)
Biomarkers Med
, vol.5
, pp. 577-584
-
-
Kumar, A.1
Asano, E.2
Chugani, H.T.3
-
41
-
-
80054806792
-
Molecular biomarkers of epileptogenesis
-
Pitkänen A, Lukasiuk K Molecular biomarkers of epileptogenesis. Biomarkers Med 2011, 5:629-633.
-
(2011)
Biomarkers Med
, vol.5
, pp. 629-633
-
-
Pitkänen, A.1
Lukasiuk, K.2
-
42
-
-
80054797400
-
Brain inflammation as a biomarker in epilepsy
-
Vezzani A, Friedman A Brain inflammation as a biomarker in epilepsy. Biomarkers Med 2011, 5:607-614.
-
(2011)
Biomarkers Med
, vol.5
, pp. 607-614
-
-
Vezzani, A.1
Friedman, A.2
-
43
-
-
84891714244
-
Proposal for a "phase II" multicenter trial model for preclinical new antiepilepsy therapy development
-
O'Brien TJ, Ben-Menachem E, Bertram EH, et al. Proposal for a "phase II" multicenter trial model for preclinical new antiepilepsy therapy development. Epilepsia 2013, 54(suppl 4):70-74.
-
(2013)
Epilepsia
, vol.54
, Issue.SUPPL. 4
, pp. 70-74
-
-
O'Brien, T.J.1
Ben-Menachem, E.2
Bertram, E.H.3
-
44
-
-
80052248654
-
Reliability of 'new drug target' claims called into question
-
Mullard A Reliability of 'new drug target' claims called into question. Nat Rev Drug Discov 2011, 10:643-644.
-
(2011)
Nat Rev Drug Discov
, vol.10
, pp. 643-644
-
-
Mullard, A.1
-
45
-
-
80055088241
-
Believe it or not: how much can we rely on published data on potential drug targets?
-
Prinz F, Schlange T, Asadullah K Believe it or not: how much can we rely on published data on potential drug targets?. Nat Rev Drug Discov 2011, 10:712.
-
(2011)
Nat Rev Drug Discov
, vol.10
, pp. 712
-
-
Prinz, F.1
Schlange, T.2
Asadullah, K.3
-
46
-
-
84861998609
-
Should preclinical studies be registered?
-
Kimmelman J, Anderson JA Should preclinical studies be registered?. Nat Biotechnol 2012, 30:488-489.
-
(2012)
Nat Biotechnol
, vol.30
, pp. 488-489
-
-
Kimmelman, J.1
Anderson, J.A.2
-
47
-
-
84876665206
-
Power failure: why small sample size undermines the reliability of neuroscience
-
Button KS, Ioannidis JP, Mokrysz C, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 2013, 14:365-376.
-
(2013)
Nat Rev Neurosci
, vol.14
, pp. 365-376
-
-
Button, K.S.1
Ioannidis, J.P.2
Mokrysz, C.3
-
48
-
-
84862314830
-
Patterns of treatment response in newly diagnosed epilepsy
-
Brodie MJ, Barry SJ, Bamagous GA, Norrie JD, Kwan P Patterns of treatment response in newly diagnosed epilepsy. Neurology 2012, 78:1548-1554.
-
(2012)
Neurology
, vol.78
, pp. 1548-1554
-
-
Brodie, M.J.1
Barry, S.J.2
Bamagous, G.A.3
Norrie, J.D.4
Kwan, P.5
-
49
-
-
79952756154
-
Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism
-
Baillie TA, Rettie AE Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism. Drug Metab Pharmacokinet 2011, 26:15-29.
-
(2011)
Drug Metab Pharmacokinet
, vol.26
, pp. 15-29
-
-
Baillie, T.A.1
Rettie, A.E.2
|